AFT Pharmaceuticals - Latest News [Page 1]

AFT Pharmaceuticals on track to return to profitability

Thursday, 22 November 2018, 9:28 am | AFT Pharmaceuticals

AFT Pharmaceuticals, manufacturer of the Maxigesic painkiller, significantly shrunk its first half loss to $0.1million from $6.7 million in the prior period, saying it remains on track to return to profitability in this financial year. More >>

Prescription-only codeine medicines in New Zealand welcomed

Thursday, 18 January 2018, 12:13 pm | AFT Pharmaceuticals

Prescription-only codeine medicines in New Zealand welcomed Yesterday the Medicines Classification Committee announced its recommendation that all codeine combination medicines, both analgesics and those used for cough and colds, should be up-scheduled ... More >>

AFT Pharmaceuticals celebrates 20 years of success

Friday, 1 September 2017, 10:08 am | AFT Pharmaceuticals

Twenty years ago this week, husband and wife Dr Hartley Atkinson and Marree Atkinson, started AFT Pharmaceuticals (AFT) in a room off their home garage. More >>

Maxigesic now licensed in 124 countries worldwide

Thursday, 20 July 2017, 12:52 pm | AFT Pharmaceuticals

AFT Pharmaceutical’s painkiller Maxigesic now licensed in 124 countries worldwide AFT Pharmaceuticals (‘AFT’) has added to its existing agreements in concluding an alliance with a private European pharmaceutical company, Amicus SA Switzerland ... More >>

AFT Pharmaceuticals In-Licenses NovaTears® in Australia & NZ

Tuesday, 21 March 2017, 11:37 am | AFT Pharmaceuticals

AFT Pharmaceuticals (AFT) has completed a licensing agreement with Novaliq, a German specialty pharmaceutical company, to distribute NovaTears® in Australia and New Zealand. More >>

TGA decision will boost Maxigesic sales in Australia

Tuesday, 20 December 2016, 11:33 am | AFT Pharmaceuticals

The Australian Therapeutic Goods Administration has today confirmed an interim decision that all medicines containing codeine be rescheduled to prescription-only medicines effective 1 February 2018. More >>

We all need to play our part in reducing antibiotic use

Tuesday, 22 November 2016, 11:18 am | AFT Pharmaceuticals

Managing Director of AFT Pharmaceuticals, Dr Hartley Atkinson, says that the pharmaceutical industry needs to take a leading role in helping reduce antibiotic use. More >>

New agreement for AFT Pharmaceuticals with Belgian Pharma

Friday, 23 September 2016, 11:39 am | AFT Pharmaceuticals

AFT Pharmaceuticals (‘AFT’) has executed an alliance agreement with privately-owned pharmaceutical company, Therabel Pharma NV (‘Therabel’), to license the product line of its patented combination painkiller, Maxigesic, to Belgium and Luxembourg. More >>

AFT Pharmaceuticals strengthens Asian operations

Tuesday, 10 May 2016, 11:32 am | AFT Pharmaceuticals

AFT Pharmaceuticals (AFT) is continuing to build its business operations in South East Asia by moving to the appointment of a Business Manager based in its Kuala Lumpur office in Malaysia. More >>

Maxigesic to carry Gold Cross logo

Friday, 18 March 2016, 11:12 am | AFT Pharmaceuticals

Australia and New Zealand pharmaceutical company, AFT Pharmaceuticals, has today announced that specific 24 tablet packets of its Maxigesic analgesic will soon carry the Pharmacy Guild of Australia’s ‘Gold Cross’ logo. More >>

AFT Pharmaceuticals lists on the NZX Main Board and ASX

Tuesday, 22 December 2015, 2:17 pm | AFT Pharmaceuticals

Shares in AFT Pharmaceuticals Limited (“AFT”), began trading on the NZX Main Board and ASX today following the successful IPO that raised $35.6 million through the issue and sale of new and existing shares. More >>

AFT Pharmaceuticals considering an IPO

Friday, 9 October 2015, 10:02 am | AFT Pharmaceuticals

AFT Pharmaceuticals considering an IPO to accelerate international growth \ Growing New Zealand and Australia based multinational pharmaceutical company, AFT Pharmaceuticals, has announced today that it is considering an initial public offering and listing ... More >>

Further US investment in AFT Pharmaceuticals

Thursday, 28 May 2015, 9:23 am | AFT Pharmaceuticals

Specialty Australasian pharmaceutical sales and development company, AFT Pharmaceuticals Ltd (AFT), has finalised a follow-on equity capital raise with CRG (formerly Capital Royalty L.P.), Atkinson family, AFT board members, and a group of specialist pharma ... More >>

Doctors have alternatives to topical treatments

Thursday, 19 March 2015, 1:13 pm | AFT Pharmaceuticals

Infectious disease experts this week drew attention to the growing link between topical antibiotic treaments in New Zealand and the superbug MRSA. More >>

NZ pharmacists concerned about codeine-based analgesics

Thursday, 5 March 2015, 12:33 pm | AFT Pharmaceuticals

An independent survey of New Zealand pharmacists has revealed that many pharmacists have significant concerns about over-the-counter (OTC) codeine-based analgesics. More >>

Kiwi company secures funding for international growth

Monday, 19 May 2014, 1:15 pm | AFT Pharmaceuticals

Auckland pharmaceutical company, AFT Pharmaceuticals, has secured major capital investment from United States and New Zealand investors that will allow the company to make further inroads into the global pharmaceutical market. More >>

Views of NZ self-medication body at odds with safety

Tuesday, 25 March 2014, 1:32 pm | AFT Pharmaceuticals

AFT Pharmaceuticals (AFT) has identified a major error with the formulation of over 1300 cold and flu products used around the world. Many over-the-counter (OTC) cold and flu products combine phenylephrine and paracetamol. More >>

NZ company finds major error with cold and flu products

Thursday, 20 March 2014, 11:27 am | AFT Pharmaceuticals

New Zealand company finds major formulation error with cold and flu products worth NZ$1.4 billion worldwide More >>

Codeine A Conundrum For Kiwi Consumers

Sunday, 1 August 2010, 11:51 am | AFT Pharmaceuticals

A survey has found about a quarter (24 per cent) of New Zealanders who used an over-the-counter painkiller in the past three months took one which contained codeine – and half of those people (47 per cent) consumed the addictive drug unwittingly. More >>

Kiwi Co. pops pill into US$20b pain-relief market

Wednesday, 28 October 2009, 10:16 am | AFT Pharmaceuticals

New Zealanders will find a home-grown answer to pain relief on the shelves at their local pharmacy this month with the launch of a new drug that represents a world breakthrough. New Zealand-owned AFT Pharmaceuticals has commercialised a new pain relief tablet, ... More >>



InfoPages Links